These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10225838)

  • 1. Comparison of the frequencies and levels of human immunodeficiency virus type 1 markers in specimens from chronically infected human T-lymphocyte cultures and from patients.
    Witt DJ; Ginocchio CC; Wang XP; Kaufman MK
    Clin Diagn Lab Immunol; 1999 May; 6(3):369-76. PubMed ID: 10225838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
    Kappes JC; Saag MS; Shaw GM; Hahn BH; Chopra P; Chen S; Emini EA; McFarland R; Yang LC; Piatak M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):139-49. PubMed ID: 7552477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
    Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
    Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals.
    Ribas SG; Ondoa P; Schüpbach J; van der Groen G; Fransen K
    J Virol Methods; 2003 Oct; 113(1):29-34. PubMed ID: 14500124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients.
    Moradbeigi M; SeyedAlinaghi S; Sajadipour M; Dadras O; Shojaei E; Ahmadi P; Bayanolhagh S; Baesi K; Rasoolinejad M
    Infect Disord Drug Targets; 2020; 20(5):752-757. PubMed ID: 31682214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal.
    Ondoa P; Dieye TN; Vereecken C; Camara M; Diallo AA; Fransen K; Litzroth A; Mboup S; Kestens L
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):416-24. PubMed ID: 16652048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.
    Böni J; Opravil M; Tomasik Z; Rothen M; Bisset L; Grob PJ; Lüthy R; Schüpbach J
    AIDS; 1997 May; 11(6):F47-52. PubMed ID: 9143600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
    Ledergerber B; Flepp M; Böni J; Tomasik Z; Cone RW; Lüthy R; Schüpbach J
    J Infect Dis; 2000 Apr; 181(4):1280-8. PubMed ID: 10751136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and virological markers of disease progression in HIV-infected children.
    Muñoz-Fernández MA; Navarro J; Obregón E; Arias RA; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Acta Paediatr Suppl; 1997 Jun; 421():46-51. PubMed ID: 9240857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
    Merigan TC; Hirsch RL; Fisher AC; Meyerson LA; Goldstein G; Winters MA
    AIDS; 1996 Feb; 10(2):159-65. PubMed ID: 8838703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.
    Prado JG; Shintani A; Bofill M; Clotet B; Ruiz L; Martinez-Picado J
    J Clin Microbiol; 2004 Apr; 42(4):1620-5. PubMed ID: 15071015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
    Fiscus SA; Hughes MD; Lathey JL; Pi T; Jackson B; Rasheed S; Elbeik T; Reichman R; Japour A; Byington R; Scott W; Griffith BP; Katzenstein DA; Hammer SM
    J Infect Dis; 1998 Mar; 177(3):625-33. PubMed ID: 9498441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load.
    Goldschmidt PL; Devillechabrolle A; Ait-Arkoub Z; Aubin JT
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):513-8. PubMed ID: 9665959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of HIV-1 cell-free viremia.
    Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
    JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons.
    Bruisten SM; Frissen PH; Van Swieten P; Harrigan PR; Kinghorn I; Larder B; Weigel HM; De Vries E; Regez RM; Henrichs JH; Koot M; Huisman JG
    AIDS Res Hum Retroviruses; 1997 Mar; 13(4):327-35. PubMed ID: 9071432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.